We are live on ! Find out more
Renaissance Technologies

Renaissance Technologies Portfolio holdings

AUM $63.9B
1-Year Est. Return 45.56%
 

Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.

This Fund
S&P 500
This Quarter Est. Return
+8.19%
1 Year Est. Return
+45.56%
3 Year Est. Return
+129.95%
5 Year Est. Return
+153.6%
10 Year Est. Return
+738.07%
AUM
$73.1B
AUM Growth
+$2.4B
Cap. Flow
-$1.43B
Cap. Flow %
-1.96%
Top 10 Hldgs %
11.25%
Holding
4,601
New
626
Increased
1,390
Reduced
2,018
Closed
524

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$839M
2
AMZN icon
Amazon
AMZN
+$810M
3
TSLA icon
Tesla
TSLA
+$644M
4
TSM icon
TSMC
TSM
+$546M
5
JNJ icon
Johnson & Johnson
JNJ
+$389M

Top Sells

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$891M
2
HD icon
Home Depot
HD
+$441M
3
JPM icon
JPMorgan Chase
JPM
+$335M
4
NVO
Novo Nordisk
NVO
+$317M
5
ASML icon
ASML
ASML
+$315M

Sector Composition

Rank Sector Weight
1 Healthcare 20.81%
2 Technology 15.51%
3 Consumer Discretionary 11.84%
4 Consumer Staples 10.09%
5 Financials 9.61%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
OTMO
3751
DELISTED
Otonomo Technologies Ltd. Ordinary shares
OTMO
$63K ﹤0.01%
10,253
-27,982
-73% -$150K
LABP
3752
DELISTED
Landos Biopharma, Inc. Common Stock
LABP
$63K ﹤0.01%
12,540
-13,330
-52% -$51K
NAK
3753
Northern Dynasty Minerals
NAK
$902M
$62K ﹤0.01%
280,900
+119,350
+74% +$28.8K
PHIO icon
3754
Phio Pharmaceuticals
PHIO
$12.8M
$62K ﹤0.01%
1,544
-434
-22% -$22.3K
SOL
3755
DELISTED
Emeren Group
SOL
$62K ﹤0.01%
13,700
-9,200
-40% -$42.5K
TISI icon
3756
Team
TISI
$79.1M
$62K ﹤0.01%
11,869
-2,260
-16% -$17.2K
TKLF
3757
Yoshitsu Co
TKLF
$8.76M
$62K ﹤0.01%
5,054
-106
-2% -$1.37K
BSQR
3758
DELISTED
BSQUARE Corporation
BSQR
$62K ﹤0.01%
55,120
-31,198
-36% -$34.4K
CVU icon
3759
CPI Aerostructures
CVU
$66M
$61K ﹤0.01%
+19,100
New +$50.6K
MYSE
3760
Myseum.AI Inc
MYSE
$12.1M
$61K ﹤0.01%
24,670
+2,075
+9% +$10.8K
MTNB icon
3761
Matinas BioPharma
MTNB
$1.75M
$61K ﹤0.01%
2,422
+1,746
+258% +$58.1K
CMCT
3762
Creative Media & Community Trust
CMCT
$12.9M
-1
Closed -$149K
LVO icon
3763
LiveOne
LVO
$61.9M
$60K ﹤0.01%
9,330
+1,830
+24% +$12.5K
VRPX
3764
DELISTED
Virpax Pharmaceuticals, Inc. Common Stock
VRPX
$60K ﹤0.01%
385
-248
-39% -$56.5K
APRE icon
3765
Aprea Therapeutics
APRE
$7.44M
$59K ﹤0.01%
8,960
-5,167
-37% -$54.5K
GPGI
3766
GPGI Inc
GPGI
$4.55B
$59K ﹤0.01%
+14,448
New +$60K
FNCH
3767
DELISTED
Finch Therapeutics Group, Inc. Common Stock
FNCH
$59K ﹤0.01%
4,097
+2,744
+203% +$91.8K
STAB
3768
DELISTED
Statera Biopharma, Inc. Common Stock
STAB
$59K ﹤0.01%
722,390
-634,556
-47% -$80.5K
CLBT icon
3769
Cellebrite
CLBT
$3.92B
$58K ﹤0.01%
+13,300
New +$59.4K
COOK icon
3770
Traeger
COOK
$191M
$58K ﹤0.01%
412
+210
+104% +$35.1K
SHIP icon
3771
Seanergy Maritime Holdings
SHIP
$375M
$58K ﹤0.01%
11,750
-30,310
-72% -$151K
IMPL
3772
DELISTED
Impel Pharmaceuticals Inc. Common Stock
IMPL
$58K ﹤0.01%
15,400
-2,000
-11% -$7.29K
CHRN
3773
ChronoScale Holdings
CHRN
$3.58B
$57K ﹤0.01%
3,174
+14
+0.4% +$289
WINT
3774
DELISTED
Windtree Therapeutics
WINT
$57K ﹤0.01%
7
WTER
3775
DELISTED
The Alkaline Water Company Inc. Common Stock
WTER
$57K ﹤0.01%
+21,780
New +$82.4K

Similar funds

Renaissance Technologies's Q4 2022 Portfolio in Review

As of Q4 2022, Renaissance Technologies held 4,601 positions worth $73.1B, up 3.4% from $70.7B the previous quarter. Its ten largest holdings account for 11% of the portfolio.

Renaissance Technologies's Q4 2022 filing shows 626 new, 1,390 increased, 2,018 reduced and 524 closed positions. Its largest new stake was Johnson & Johnson: 2,254,125 shares worth $398M. The largest sale was Microsoft, an estimated $891M.

By sector, the portfolio is most concentrated in Healthcare at 21% of assets, up from 19% a quarter earlier, followed by Technology and Consumer Discretionary.

  • Renaissance Technologies's largest Q4 2022 buy was Johnson & Johnson: 2,254,125 shares worth $398M.
  • Renaissance Technologies added most to Apple in Q4 2022, an estimated $839M increase.
  • Renaissance Technologies's biggest Q4 2022 reduction was Novo Nordisk, cutting an estimated $317M.
  • Renaissance Technologies fully exited Microsoft in Q4 2022, selling an estimated $891M.
  • Renaissance Technologies's ten largest holdings make up 11% of its $73.1B portfolio in Q4 2022.
  • Renaissance Technologies opened 626 new positions and closed 524 in Q4 2022.
  • Renaissance Technologies's portfolio value rose 3.4% quarter-over-quarter to $73.1B.

Based on Renaissance Technologies's 13F filing for Q4 2022, filed 13 Feb 2023.